Industry News

Global Coagulation Analyzers Market Driven by Growing Awareness About Timely Diagnosis of Blood Clots

By Labmedica International staff writers
18 Jan 2022


The global coagulation analyzers market is expected to reach USD 11.7 billion by 2028, driven by the increasing understanding of blood clots and the fact that they can be avoided with early detection.

These are the latest findings of Reports and Data (New York City, NY, USA), a market research and consulting company.

Genetic disorders, as well as vitamin K deficiency and heart disease, can contribute to blood clotting. Without warning, people with pulmonary embolism sometimes die. Hence, an increase in incidences of blood clotting and the need for early detection to save lives are driving the growth of the global market for coagulation analyzers.

However, limited knowledge of timely blood clot detection and lack of qualified coagulation analyzers will hamper market growth. A substantial portion of the population in the developed countries is also unaware of the need for routine check-ups. People do not have access to proper healthcare in several under-privileged nations. These factors can pose significant challenges to the growth of the global coagulation analyzers market.

Based on product, the analyzers segment held the highest share in terms of sales of the coagulation analyzers market in 2020 and is projected to record a significant growth over the coming years. On the basis of technology, the optical technology segment is expected to hold the highest market share in the coagulation analyzers market due to the combination of immunological, chromogenic and photo-optical techniques that have resulted in the development of high-performance, multipurpose optical haemostasis analyzers.

Based on test type, the D-dimer segment is projected to account for the largest share of the coagulation analyzers market. On the basis of end-use, the clinical laboratory segment held the largest share of the coagulation analyzers market in 2020. For routine hematological examination of patients, clinical laboratory analyzers are generally used in hospitals. Based on commodity, the consumables segment holds the largest share of the coagulation analyzers market. All tests require reagents and hence, large inventories or repeat orders of these materials are maintained by hospitals, resulting in greater demand. Sales of consumables are also expected to increase along with the increase in research and development of new assays.

Geographically, the Asia Pacific coagulation analyzers market is expected to experience a lucrative growth due to sufficient hospitals, health centers and clinics in the region. With economic growth and improved access to healthcare in countries with a large population such as India and China, people are paying more attention to their health, thus generating growth opportunities for the coagulation analyzers market in the Asia Pacific region.

Related Links:
Reports and Data 

E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

20 May 2022
Qiagen Acquires Enzymes Provider Blirt to Strengthen Sample Technologies Business
QIAGEN N.V. (Venlo, Netherlands) has signed agreements to acquire a 96% majority ownership stake in BLIRT S.A. (Gdansk, Poland), a manufacturer of recombinant enzymes for the life science industry.
Read More
16 May 2022
Medtronic Completes Acquisition of Intersect ENT to Add Innovative Sinus Implants to ENT Portfolio
Medtronic plc (Dublin, Ireland) has completed the acquisition of Intersect ENT (Menlo Park, CA, USA), thereby expanding the company's comprehensive ear, nose, and throat (ENT) portfolio with innovative products used in sinus procedures to improve post-operative outcomes and to treat nasal polyps.
Read More
12 May 2022
Global Lateral Flow Assays Market to Surpass USD 11.5 Billion by 2032 Due to Evolving Applications
The global lateral flow assays market is projected to register a CAGR of 4.7% during 2022-2032 to surpass USD 11.7 billion by the end of 2032, driven by the growing prevalence of influenza, STDs, and tuberculosis worldwide and rising awareness among people about the availability of POCT kits.
Read More
11 May 2022
Global Rapid Test Kits Market Driven by Immunoassay and Chromatography-Based Tests
The global rapid test kits market size was valued at more than USD 25.50 billion in 2021 and is expected to register a CAGR of 8.1% over the 2019-2030 period to surpass USD 52 billion in 2030, driven primarily by the increasing prevalence of various infectious diseases.
Read More
03 May 2022
Meridian Acquires Euprotein to Further Expand Recombinant Protein Capabilities
Meridian Bioscience, Inc. (Cincinnati, OH, USA) has acquired, through its subsidiary Meridian Life Science, Inc., substantially all of the assets of EUPROTEIN Inc. (North Brunswick Township, NJ, USA).
Read More
02 May 2022
Globe Scientific Acquired by L Squared Capital Partners
Globe Scientific (Mahwah, NJ, USA), a provider of laboratory consumable supplies, has been acquired by L Squared Capital Partners (Newport Beach, CA, USA), marking its third acquisition as part of GSI Group Holdings.
Read More
29 Apr 2022
GE Healthcare and Medtronic Collaborate to Improve Product Access for ASCs and OBLs
GE Healthcare (Chicago, IL, USA) and Medtronic (Doral, FL, USA) have entered into a collaboration focused on the unique needs and demand for care at Ambulatory Surgery Centers (ASCs) and Office Based Labs (OBLs) that will allow customers to access extensive product portfolios, financial solutions, and exceptional service.
Read More
22 Apr 2022
Global Diagnostic Imaging Market to Surpass USD 33 Billion by 2026
The global diagnostic imaging market is projected to grow at a CAGR of 4.9% from an estimated USD 27.5 billion in 2022 to over USD 33 billion by 2026, driven by technological advancements, favorable demographic factors in the developed regions, growing access to healthcare and rising income levels of the middle class population in the developing regions.
Read More
22 Apr 2022
Global Electrosurgery Market to Reach Almost USD 6 Billion by 2026
The global electrosurgery market is projected to grow at a CAGR of 3.6% from an estimated USD 5 billion in 2022 to almost USD 6 billion by 2026, driven by the rapidly rising number of surgeries being performed globally, an aging population, and increasing prevalence of various chronic diseases.
Read More
Copyright © 2000-2022 All rights reserved. | Terms And Conditions